Stockreport

Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders

Phio Pharmaceuticals Corp.  (PHIO) 
Last phio pharmaceuticals corp. earnings: 11/12 07:45 am Check Earnings Report
PDF MARLBOROUGH, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siR [Read more]